Call Options

19 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$772.14 - $960.02 $784 Million - $975 Million
1,015,200 New
1,015,200 $899 Million
Q1 2022

May 17, 2022

BUY
$234.69 - $291.66 $17.7 Million - $22 Million
75,500 Added 26.22%
363,400 $104 Million
Q4 2021

Feb 15, 2022

SELL
$224.85 - $279.04 $5.08 Million - $6.31 Million
-22,600 Reduced 7.28%
287,900 $79.5 Million
Q3 2021

Nov 16, 2021

BUY
$221.6 - $272.71 $6.67 Million - $8.21 Million
30,100 Added 10.73%
310,500 $71.7 Million
Q2 2021

Aug 16, 2021

BUY
$180.55 - $233.54 $17.8 Million - $23.1 Million
98,700 Added 54.32%
280,400 $64.4 Million
Q1 2021

May 18, 2021

SELL
$164.32 - $212.72 $4.03 Million - $5.21 Million
-24,500 Reduced 11.88%
181,700 $33.9 Million
Q4 2020

Feb 17, 2021

BUY
$130.46 - $172.63 $6.64 Million - $8.79 Million
50,900 Added 32.78%
206,200 $34.8 Million
Q3 2020

Nov 17, 2020

SELL
$146.22 - $169.13 $14.1 Million - $16.3 Million
-96,400 Reduced 38.3%
155,300 $23 Million
Q2 2020

Aug 17, 2020

BUY
$136.42 - $164.18 $15 Million - $18.1 Million
110,200 Added 77.88%
251,700 $41.3 Million
Q1 2020

May 15, 2020

BUY
$119.05 - $147.35 $5.85 Million - $7.23 Million
49,100 Added 53.14%
141,500 $19.6 Million
Q4 2019

Feb 14, 2020

BUY
$106.92 - $132.43 $3.22 Million - $3.99 Million
30,100 Added 48.31%
92,400 $12.1 Million
Q3 2019

Nov 14, 2019

SELL
$106.79 - $116.16 $149,506 - $162,624
-1,400 Reduced 2.2%
62,300 $6.97 Million
Q2 2019

Aug 15, 2019

SELL
$110.79 - $129.32 $4.09 Million - $4.77 Million
-36,900 Reduced 36.68%
63,700 $7.06 Million
Q4 2018

Feb 15, 2019

BUY
$105.9 - $118.64 $656,580 - $735,568
6,200 Added 6.57%
100,600 $11.6 Million
Q3 2018

Nov 14, 2018

BUY
$85.86 - $107.31 $1.65 Million - $2.06 Million
19,200 Added 25.53%
94,400 $10.1 Million
Q2 2018

Aug 15, 2018

BUY
$75.7 - $86.88 $2.33 Million - $2.68 Million
30,800 Added 69.37%
75,200 $6.42 Million
Q1 2018

May 15, 2018

BUY
$74.21 - $87.6 $2.86 Million - $3.38 Million
38,600 Added 665.52%
44,400 $3.44 Million
Q4 2017

Feb 15, 2018

SELL
$81.94 - $87.89 $1.57 Million - $1.69 Million
-19,200 Reduced 76.8%
5,800 $490,000
Q3 2017

Nov 14, 2017

BUY
$77.07 - $85.54 $1.93 Million - $2.14 Million
25,000
25,000 $2.14 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $757B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.